These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 27737475)
1. Pharmacotherapy in Children and Adolescents at Clinical-High Risk for Psychosis and Bipolar Disorder. Lambert M; Niehaus V; Correll C Pharmacopsychiatry; 2016 Nov; 49(6):229-244. PubMed ID: 27737475 [TBL] [Abstract][Full Text] [Related]
3. Second generation antipsychotics (SGAs) for non-psychotic disorders in children and adolescents: a review of the randomized controlled studies. Zuddas A; Zanni R; Usala T Eur Neuropsychopharmacol; 2011 Aug; 21(8):600-20. PubMed ID: 21550212 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of second-generation antipsychotics in children and adolescents with psychotic and bipolar spectrum disorders: comprehensive review of prospective head-to-head and placebo-controlled comparisons. Fraguas D; Correll CU; Merchán-Naranjo J; Rapado-Castro M; Parellada M; Moreno C; Arango C Eur Neuropsychopharmacol; 2011 Aug; 21(8):621-45. PubMed ID: 20702068 [TBL] [Abstract][Full Text] [Related]
6. Misdiagnosis, duration of untreated illness (DUI) and outcome in bipolar patients with psychotic symptoms: A naturalistic study. Altamura AC; Buoli M; Caldiroli A; Caron L; Cumerlato Melter C; Dobrea C; Cigliobianco M; Zanelli Quarantini F J Affect Disord; 2015 Aug; 182():70-5. PubMed ID: 25978716 [TBL] [Abstract][Full Text] [Related]
7. [Guidelines for the prescription of mood stabilizers for adolescents: A literature review]. Munch G; Godart N Encephale; 2017 Oct; 43(5):464-470. PubMed ID: 27871720 [TBL] [Abstract][Full Text] [Related]
8. Interventions for youth at high risk for bipolar disorder and schizophrenia. McNamara RK; Strawn JR; Chang KD; DelBello MP Child Adolesc Psychiatr Clin N Am; 2012 Oct; 21(4):739-51. PubMed ID: 23040899 [TBL] [Abstract][Full Text] [Related]
9. Psychopharmacology of Bipolar Disorders in Children and Adolescents. Stepanova E; Findling RL Pediatr Clin North Am; 2017 Dec; 64(6):1209-1222. PubMed ID: 29173781 [TBL] [Abstract][Full Text] [Related]
10. Antipsychotic interventions in prodromal psychosis: safety issues. Liu CC; Demjaha A CNS Drugs; 2013 Mar; 27(3):197-205. PubMed ID: 23436256 [TBL] [Abstract][Full Text] [Related]
11. Treatment options for children and adolescents with bipolar disorder. Findling RL J Clin Psychiatry; 2009 Sep; 70(9):e34. PubMed ID: 19818240 [TBL] [Abstract][Full Text] [Related]
12. Antipsychotics in children and adolescents: increasing use, evidence for efficacy and safety concerns. Vitiello B; Correll C; van Zwieten-Boot B; Zuddas A; Parellada M; Arango C Eur Neuropsychopharmacol; 2009 Sep; 19(9):629-35. PubMed ID: 19467582 [TBL] [Abstract][Full Text] [Related]
13. Prescribing of antipsychotics in UK primary care: a cohort study. Marston L; Nazareth I; Petersen I; Walters K; Osborn DP BMJ Open; 2014 Dec; 4(12):e006135. PubMed ID: 25524544 [TBL] [Abstract][Full Text] [Related]
14. Toward convergence in the medication treatment of bipolar disorder and schizophrenia. Citrome L; Goldberg JF; Stahl SM Harv Rev Psychiatry; 2005; 13(1):28-42. PubMed ID: 15804932 [TBL] [Abstract][Full Text] [Related]
15. [Pharmacological treatment of bipolar disorder in children and adolescents]. Bailly D Encephale; 2017 May; 43(3):254-258. PubMed ID: 27198073 [TBL] [Abstract][Full Text] [Related]